QuantumScape Corp
Business
QuantumScape Corp develops next-generation solid-state lithium-metal battery technology for electric vehicles and other applications. Its core products include a proprietary inorganic ceramic solid-state electrolyte-separator and anode-free multilayer battery cells, exemplified by its QSE-5 prototypes, along with related catholytes and cell architectures and ongoing R&D. The company is organized around a technology licensing business model while retaining options to operate manufacturing, license to partners, or enter joint ventures, and collaborates closely with automotive OEMs and PowerCo/Volkswagen. It targets automotive markets globally and also pursues opportunities in stationary storage and consumer electronics through licensing, customer sampling, pilot production, and partnerships.
Summary from filing dated 2025-02-26
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Research and development | 376 | 383 | 348 | 297 | 151 | |
| General and administrative | 97 | 142 | 131 | 123 | 64 | |
| Total operating expenses | 473 | 525 | 479 | 421 | 215 | |
| Loss from operations | −473 | −525 | −479 | −421 | −215 | |
| Interest expense | −2 | −2 | −2 | −2 | — | |
| Interest income | 39 | 46 | 36 | 11 | 2 | |
| Other income (expense) | 3 | 3 | −140,000 | 216,000 | 151,000 | |
| Loss before income taxes | −434 | −478 | −445 | — | — | |
| Income tax (provision) benefit | −2 | 269,000 | −20,000 | — | — | |
| Net loss | −435 | −478 | −445 | −412 | −46 | |
| Less: Net (loss) income attributable to non-controlling interest, net of tax of $0 | — | −85,000 | 66,000 | 11,000 | −11,000 | |
| Net loss attributable to common stockholders | −435 | −478 | −445 | −412 | −46 | |
| Unrealized gain on marketable securities | 216,000 | 3 | 15 | −14 | −4 | |
| Total comprehensive loss | −435 | −475 | −430 | −426 | −50 | |
| Less: Comprehensive (loss) income attributable to non-controlling interest | — | −85,000 | 66,000 | 11,000 | −11,000 | |
| Comprehensive loss attributable to common stockholders | −435 | −475 | −430 | −426 | −50 | |
| Net loss per share - Basic | −0.76 | −0.94 | −0.96 | −0.95 | −0.11 | |
| Net loss per share - Diluted | −0.76 | −0.94 | −0.96 | −0.95 | −0.52 | |
| Weighted-average common shares outstanding - Basic | 576 | 508 | 462 | 433 | 404 | |
| Weighted-average common shares outstanding - Diluted | 576 | 508 | 462 | 433 | 410 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 231 | 141 | 143 | 235 | 321 | |
| Marketable securities | 740 | 770 | 928 | 826 | 1,127 | |
| Prepaid expenses and other current assets | 11 | 12 | 13 | 11 | 16 | |
| Total current assets | 982 | 922 | 1,084 | 1,072 | 1,463 | |
| Property and equipment, net | 251 | 300 | 313 | 296 | 166 | |
| Right-of-use assets - operating lease | 34 | 51 | 56 | 61 | 37 | |
| Right-of-use assets - finance lease | 19 | 22 | 25 | 28 | 31 | |
| Other assets | 22 | 26 | 24 | 18 | 18 | |
| Total assets | 1,308 | 1,322 | 1,502 | 1,475 | 1,716 | |
| Accounts payable | 12 | 6 | 13 | 21 | 14 | |
| Accrued liabilities | 15 | 17 | 10 | 7 | 6 | |
| Accrued compensation and benefits | 27 | 32 | 26 | 13 | 9 | |
| Operating lease liability, short-term | 5 | 6 | 5 | 3 | 1 | |
| Finance lease liability, short-term | 4 | 3 | 3 | 1 | 19,000 | |
| Total current liabilities | 62 | 65 | 57 | 47 | 31 | |
| Operating lease liability, long-term | 34 | 53 | 58 | 63 | 37 | |
| Finance lease liability, long-term | 28 | 32 | 35 | 38 | 39 | |
| Other liabilities | 15 | 15 | 12 | 8 | 315,000 | |
| Total liabilities | 139 | 165 | 162 | 156 | 107 | |
| Commitment and contingencies (see Note 7) | — | — | — | — | — | |
| Preferred stock- $0.0001 par value; 100,000 shares authorized, none issued and outstanding as of December 31, 2025 and 2024 | — | — | — | — | — | |
| Common stock - $0.0001 par value; 1,250,000 shares authorized (1,000,000 Class A and 250,000 Class B); 570,128 Class A and 37,502 Class B shares issued and outstanding as of December 31, 2025, 487,883 Class A and 54,666 Class B shares issued and outstanding as of December 31, 2024 | 61,000 | 54,000 | 49,000 | 44,000 | 43,000 | |
| Additional paid-in-capital | 4,962 | 4,516 | 4,222 | 3,771 | 3,635 | |
| Accumulated other comprehensive loss | 644,000 | 428,000 | −3 | −18 | −4 | |
| Accumulated deficit | −3,794 | −3,359 | −2,881 | −2,436 | −2,024 | |
| Total stockholders equity | 1,169 | 1,158 | 1,338 | 1,318 | 1,607 | |
| Total liabilities and stockholders' equity | 1,308 | 1,322 | 1,502 | 1,475 | 1,716 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Depreciation and amortization | 66 | 58 | 42 | 28 | 11 | |
| Amortization of right-of-use assets and non-cash lease expense | 8 | 8 | 8 | 8 | 3 | |
| Accretion of discounts on marketable securities | −19 | −29 | −19 | 4 | 12 | |
| Stock-based compensation expense | 128 | 145 | 166 | 127 | 52 | |
| Write-off of property and equipment | 27 | 13 | 22 | 14 | — | |
| Other | −4 | 109,000 | 469,000 | 840,000 | 899,000 | |
| Prepaid expenses and other current assets and other assets | 1 | −893,000 | −8 | 5 | −5 | |
| Accounts payable, accrued liabilities and accrued compensation and benefits | −7 | 15 | −3 | 6 | 13 | |
| Operating lease liability | −5 | −5 | −3 | −844,000 | −1 | |
| Other liabilities | −1 | −213,000 | −234,000 | 2 | — | |
| Net cash used in operating activities | −242 | −275 | −240 | −218 | −128 | |
| Purchases of property and equipment | −36 | −62 | −85 | −159 | −127 | |
| Proceeds from maturities of marketable securities | 1,126 | 1,485 | 1,042 | 837 | 894 | |
| Proceeds from sales of marketable securities | — | 1 | 1 | 15 | 224 | |
| Purchases of marketable securities | −1,077 | −1,295 | −1,111 | −570 | −1,377 | |
| Other | 2 | 116,000 | 114,000 | — | — | |
| Net cash (used in) provided by investing activities | 15 | 129 | −153 | 124 | −386 | |
| Proceeds from exercise of stock options and employee stock purchase plan | 32 | 20 | 14 | 9 | 18 | |
| Proceeds from issuance of common stock | 269 | 131 | 300 | — | 463 | |
| Principal payment for finance lease | −3 | −3 | −2 | −809,000 | 6 | |
| Cash received under collaboration agreement - related party | 20 | — | — | — | — | |
| Dissolution of joint venture | — | −2 | — | — | — | |
| Net cash provided by financing activities | 313 | 144 | 300 | 9 | 737 | |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 85 | −2 | −92 | −85 | 223 | |
| Cash paid for interest | 2 | 2 | 2 | 2 | 330,000 | |
| Purchases of property and equipment, not yet paid | 10 | 3 | 11 | 18 | 11 |